Grace Therapeutics, Inc. (GRCE) Options Chain
The options chain displays all available contracts with real-time quotes, Greeks, volume, and open interest for each strike and expiration. It is the primary tool for options trade selection.
Grace Therapeutics, Inc. (GRCE) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $34.8M, listed on NASDAQ, employing roughly 4 people, carrying a beta of 0.32 to the broader market. Grace Therapeutics, Inc. Led by Prashant Kohli, public since 2012-02-07.
Snapshot as of May 15, 2026.
- Spot Price
- $2.19
- Total OI
- 20.7K
- Total Volume
- 153
- Front Expiration
- 34 days
- Second Expiration
- 63 days
- ATM IV
- 102.3%
- Avg Bid/Ask Spread
- 98.89%
As of May 15, 2026, Grace Therapeutics, Inc. (GRCE) has 20.7K open contracts and 153 contracts traded. The nearest expiration is 34 days out, followed by 63 days. ATM implied volatility is 102.3%. Average bid/ask spread across the chain is 98.89%: wider spreads, size positions conservatively. The options chain aggregates every listed strike and expiration, letting traders evaluate skew, term structure, and liquidity in a single view.
How GRCE options chain Data Feeds Strategy Selection
Strategy selection on Grace Therapeutics, Inc. options does not derive from any single metric in isolation. The options chain view above sits inside a broader read: ATM IV currently sits at 102.3% and dealer gamma exposure is positive, so dealer hedging is mechanically mean-reverting. Combine the options chain data here with the volatility-skew surface, dealer-gamma exposure, max-pain level, and upcoming-events calendar to build a positioning thesis. Risk-defined structures (credit spreads, debit spreads, iron condors) are usually safer than naked positions while the regime is uncertain; the data on this page anchors the inputs but does not by itself constitute a trade thesis.
Learn how the options chain is reported and how to read the data →
Frequently asked GRCE options chain questions
- What does the GRCE options chain show right now?
- As of May 15, 2026, Grace Therapeutics, Inc. (GRCE) has 20.7K contracts outstanding and 153 traded today, with ATM IV of 102.3%. The full chain spans every listed strike and expiration with bid/ask, Greeks, volume, and open interest per contract.
- What expirations are available for GRCE options?
- The nearest expiration is 34 days out, followed by 63 days. Listed expirations typically extend monthly with weeklies between, plus LEAPS one to two years out for liquid names.
- How tight are GRCE options bid/ask spreads?
- Average bid/ask spread across the chain is 98.89%. Wider spreads warrant conservative sizing; mid-market fills are unreliable for retail-size orders.